See more : Xybion Digital Inc. (XYBN.V) Income Statement Analysis – Financial Results
Complete financial analysis of International Flavors & Fragrances Inc. (IFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of International Flavors & Fragrances Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Ocean Plastics Co., Ltd. (1321.TW) Income Statement Analysis – Financial Results
- Itaú Unibanco Holding S.A. (ITUB) Income Statement Analysis – Financial Results
- Intertech Solutions , Inc. (ITEC) Income Statement Analysis – Financial Results
- Houpu Clean Energy Group Co., Ltd. (300471.SZ) Income Statement Analysis – Financial Results
- Xiamen Intretech Inc. (002925.SZ) Income Statement Analysis – Financial Results
International Flavors & Fragrances Inc. (IFF)
About International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.48B | 12.44B | 11.66B | 5.08B | 5.14B | 3.98B | 3.40B | 3.12B | 3.02B | 3.09B | 2.95B | 2.82B | 2.79B | 2.62B | 2.33B | 2.39B | 2.28B | 2.10B | 1.99B | 2.03B | 1.90B | 1.81B | 1.84B | 1.46B | 1.44B | 1.41B | 1.43B | 1.44B | 1.44B | 1.32B | 1.19B | 1.13B | 1.02B | 962.80M | 869.50M | 839.50M | 745.90M | 620.70M | 501.00M |
| Cost of Revenue | 7.80B | 8.29B | 7.92B | 3.00B | 3.03B | 2.29B | 1.92B | 1.72B | 1.67B | 1.73B | 1.67B | 1.65B | 1.68B | 1.53B | 1.39B | 1.42B | 1.32B | 1.21B | 1.17B | 1.16B | 1.09B | 1.04B | 1.06B | 762.31M | 735.40M | 714.50M | 722.90M | 731.00M | 706.30M | 641.40M | 578.70M | 548.00M | 498.50M | 474.60M | 433.00M | 414.10M | 372.60M | 311.00M | 245.90M |
| Gross Profit | 3.68B | 4.15B | 3.74B | 2.09B | 2.11B | 1.68B | 1.48B | 1.40B | 1.35B | 1.36B | 1.28B | 1.18B | 1.10B | 1.09B | 935.13M | 970.63M | 952.21M | 884.13M | 824.40M | 873.42M | 809.06M | 773.41M | 780.33M | 700.49M | 704.10M | 692.80M | 703.90M | 705.10M | 733.20M | 673.80M | 609.90M | 578.40M | 518.50M | 488.20M | 436.50M | 425.40M | 373.30M | 309.70M | 255.10M |
| Gross Profit Ratio | 32.07% | 33.37% | 32.04% | 41.03% | 41.10% | 42.31% | 43.52% | 44.89% | 44.71% | 44.10% | 43.49% | 41.66% | 39.62% | 41.66% | 40.20% | 40.62% | 41.83% | 42.19% | 41.36% | 42.95% | 42.55% | 42.75% | 42.32% | 47.89% | 48.91% | 49.23% | 49.33% | 49.10% | 50.93% | 51.23% | 51.31% | 51.35% | 50.98% | 50.71% | 50.20% | 50.67% | 50.05% | 49.90% | 50.92% |
| Research & Development | 636.00M | 603.00M | 629.00M | 356.86M | 346.13M | 311.58M | 286.03M | 254.26M | 246.10M | 253.64M | 259.84M | 233.71M | 219.78M | 218.77M | 193.84M | 212.70M | 199.02M | 185.69M | 179.81M | 175.17M | 159.29M | 144.03M | 135.25M | 112.67M | 103.80M | 98.40M | 94.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 707.46M | 557.31M | 566.22M | 509.56M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.79B | 1.77B | 1.75B | 948.83M | 876.12M | 707.46M | 557.31M | 566.22M | 520.09M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 268.90M | 280.80M | 234.80M | 220.70M | 198.10M | 191.80M | 173.70M | 151.40M | 125.70M |
| Other Expenses | 0.00 | 727.00M | 732.00M | 192.61M | 193.10M | 35.24M | 20.97M | 9.35M | -3.18M | 2.81M | 15.64M | -1.45M | 0.00 | 0.00 | 6.15M | 6.15M | 12.88M | 14.84M | 15.07M | 14.83M | 12.63M | 12.63M | 46.09M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
| Operating Expenses | 5.79B | 3.10B | 3.11B | 1.50B | 1.42B | 1.09B | 878.03M | 844.25M | 766.19M | 768.53M | 765.72M | 687.25M | 663.76M | 666.16M | 576.54M | 600.69M | 587.19M | 552.46M | 534.21M | 531.31M | 480.87M | 461.82M | 494.67M | 440.67M | 422.80M | 386.10M | 371.80M | 364.80M | 349.20M | 325.20M | 304.00M | 314.80M | 264.20M | 248.90M | 222.40M | 214.50M | 194.40M | 169.80M | 140.30M |
| Cost & Expenses | 13.62B | 11.39B | 11.03B | 4.50B | 4.44B | 3.39B | 2.80B | 2.56B | 2.44B | 2.49B | 2.43B | 2.33B | 2.35B | 2.20B | 1.97B | 2.02B | 1.91B | 1.76B | 1.70B | 1.69B | 1.57B | 1.50B | 1.56B | 1.20B | 1.16B | 1.10B | 1.09B | 1.10B | 1.06B | 966.60M | 882.70M | 862.80M | 762.70M | 723.50M | 655.40M | 628.60M | 567.00M | 480.80M | 386.20M |
| Interest Income | 0.00 | 336.00M | 289.00M | 132.00M | 138.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 380.00M | 336.00M | 289.00M | 131.80M | 138.22M | 132.56M | 65.36M | 52.99M | 46.06M | 46.07M | 46.77M | 41.75M | 44.64M | 48.71M | 61.82M | 74.01M | 41.54M | 25.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.14B | 1.18B | 1.16B | 325.36M | 323.33M | 173.79M | 117.97M | 102.47M | 89.60M | 89.35M | 83.23M | 76.67M | 75.33M | 79.24M | 78.53M | 75.99M | 82.79M | 89.73M | 91.93M | 91.00M | 86.72M | 84.46M | 123.49M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
| EBITDA | -996.00M | -110.00M | 1.80B | 897.68M | 1.02B | 753.60M | 719.59M | 678.58M | 674.76M | 684.21M | 615.00M | 561.84M | 493.51M | 487.54M | 412.89M | 430.52M | 442.62M | 428.56M | 402.17M | 470.21M | 414.92M | 396.06M | 409.15M | 329.16M | 337.70M | 355.75M | 382.40M | 388.10M | 424.70M | 385.00M | 341.00M | 297.60M | 283.70M | 267.50M | 238.40M | 233.60M | 199.60M | 158.30M | 129.40M |
| EBITDA Ratio | -8.68% | 18.24% | 15.78% | 18.09% | 20.45% | 20.03% | 21.77% | 21.39% | 22.22% | 22.20% | 20.91% | 19.97% | 18.52% | 19.28% | 18.79% | 18.78% | 19.44% | 19.77% | 20.18% | 23.12% | 24.34% | 22.34% | 23.68% | 25.96% | 25.72% | 24.82% | 26.07% | 29.69% | 28.61% | 27.36% | 25.74% | 23.73% | 25.46% | 24.17% | 25.52% | 27.05% | 25.93% | 25.00% | 24.93% |
| Operating Income | -2.11B | 1.09B | 585.00M | 566.48M | 665.27M | 583.88M | 581.44M | 567.36M | 577.82M | 592.32M | 518.49M | 488.29M | 440.90M | 416.36M | 358.59M | 351.73M | 365.03M | 328.99M | 266.88M | 310.28M | 285.77M | 311.60M | 285.66M | 259.82M | 281.30M | 306.70M | 332.10M | 340.30M | 384.00M | 348.60M | 305.90M | 263.60M | 254.30M | 239.30M | 214.10M | 210.90M | 178.90M | 139.90M | 114.80M |
| Operating Income Ratio | -18.38% | 8.76% | 5.02% | 11.14% | 12.94% | 14.68% | 17.11% | 18.21% | 19.11% | 19.18% | 17.56% | 17.31% | 15.81% | 15.87% | 15.42% | 14.72% | 16.03% | 15.70% | 13.39% | 15.26% | 15.03% | 17.22% | 15.49% | 17.76% | 19.54% | 21.79% | 23.28% | 23.70% | 26.68% | 26.51% | 25.74% | 23.40% | 25.00% | 24.85% | 24.62% | 25.12% | 23.98% | 22.54% | 22.91% |
| Total Other Income/Expenses | -408.00M | -299.00M | -231.00M | -125.11M | -157.55M | -136.13M | -100.26M | -43.64M | -49.25M | -43.26M | -55.06M | -44.87M | -67.36M | -67.06M | -63.74M | -91.42M | -36.34M | -15.39M | -44.01M | -61.11M | -33.91M | -45.18M | -97.88M | -75.69M | -37.80M | 4.40M | 8.10M | -41.20M | 9.70M | 11.70M | 17.90M | 17.90M | 15.20M | 12.80M | 9.00M | -1.60M | -3.50M | -600.00K | -2.20M |
| Income Before Tax | -2.52B | -1.63B | 354.00M | 441.37M | 557.45M | 447.76M | 537.05M | 523.72M | 528.57M | 549.06M | 485.21M | 443.42M | 373.55M | 359.59M | 276.55M | 280.52M | 328.68M | 313.28M | 246.19M | 281.00M | 251.86M | 266.42M | 187.78M | 184.13M | 243.50M | 311.10M | 340.20M | 299.10M | 393.70M | 360.30M | 323.80M | 281.50M | 269.50M | 252.10M | 223.10M | 209.30M | 175.40M | 139.30M | 112.60M |
| Income Before Tax Ratio | -21.94% | -13.06% | 3.04% | 8.68% | 10.85% | 11.26% | 15.80% | 16.81% | 17.48% | 17.78% | 16.43% | 15.72% | 13.40% | 13.71% | 11.89% | 11.74% | 14.44% | 14.95% | 12.35% | 13.82% | 13.25% | 14.73% | 10.18% | 12.59% | 16.92% | 22.11% | 23.84% | 20.83% | 27.35% | 27.40% | 27.24% | 24.99% | 26.50% | 26.18% | 25.66% | 24.93% | 23.52% | 22.44% | 22.48% |
| Income Tax Expense | 45.00M | 211.00M | 75.00M | 74.00M | 97.18M | 107.98M | 241.38M | 118.69M | 116.91M | 134.52M | 131.67M | 189.28M | 106.68M | 96.04M | 81.02M | 50.89M | 81.56M | 86.78M | 53.12M | 84.93M | 79.26M | 90.47M | 71.78M | 61.12M | 81.50M | 107.30M | 122.00M | 109.20M | 144.90M | 134.30M | 121.30M | 104.80M | 100.80M | 95.40M | 84.50M | 80.60M | 68.40M | 53.60M | 42.90M |
| Net Income | -2.57B | -1.84B | 268.00M | 365.00M | 455.87M | 337.30M | 295.67M | 405.03M | 411.67M | 414.54M | 353.54M | 254.13M | 266.87M | 263.56M | 195.53M | 229.63M | 247.13M | 226.50M | 193.07M | 196.07M | 172.60M | 175.94M | 116.00M | 123.01M | 162.00M | 203.80M | 218.20M | 189.90M | 248.80M | 226.00M | 202.50M | 170.60M | 168.70M | 156.70M | 138.60M | 128.70M | 107.00M | 85.70M | 69.70M |
| Net Income Ratio | -22.35% | -14.76% | 2.30% | 7.18% | 8.87% | 8.48% | 8.70% | 13.00% | 13.62% | 13.42% | 11.97% | 9.01% | 9.57% | 10.05% | 8.41% | 9.61% | 10.85% | 10.81% | 9.69% | 9.64% | 9.08% | 9.72% | 6.29% | 8.41% | 11.25% | 14.48% | 15.29% | 13.22% | 17.28% | 17.18% | 17.04% | 15.15% | 16.59% | 16.28% | 15.94% | 15.33% | 14.35% | 13.81% | 13.91% |
| EPS | -10.06 | -7.20 | 1.10 | 3.25 | 4.04 | 3.85 | 3.73 | 5.07 | 5.19 | 5.09 | 4.32 | 3.11 | 3.30 | 3.29 | 2.48 | 2.89 | 2.86 | 2.50 | 2.06 | 2.08 | 1.84 | 1.86 | 1.21 | 1.22 | 1.53 | 1.90 | 2.00 | 1.71 | 2.24 | 2.03 | 1.78 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
| EPS Diluted | -10.06 | -7.20 | 1.10 | 3.20 | 4.00 | 3.83 | 3.72 | 5.05 | 5.16 | 5.06 | 4.29 | 3.09 | 3.26 | 3.26 | 2.46 | 2.86 | 2.82 | 2.48 | 2.04 | 2.05 | 1.83 | 1.84 | 1.20 | 1.22 | 1.53 | 1.90 | 1.99 | 1.70 | 2.24 | 2.03 | 1.77 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
| Weighted Avg Shares Out | 255.00M | 255.00M | 243.00M | 112.16M | 111.97M | 87.55M | 79.07M | 79.65M | 80.45M | 80.94M | 81.32M | 81.11M | 80.46M | 79.50M | 78.40M | 79.03M | 86.54M | 90.60M | 93.72M | 94.26M | 93.80M | 94.59M | 95.87M | 100.82M | 105.88M | 107.26M | 109.10M | 111.05M | 111.07M | 111.33M | 113.76M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
| Weighted Avg Shares Out (Dil) | 255.00M | 255.00M | 243.00M | 113.63M | 113.31M | 88.12M | 79.37M | 79.98M | 80.89M | 81.49M | 81.93M | 81.83M | 81.47M | 80.44M | 79.09M | 79.72M | 87.63M | 91.33M | 94.64M | 95.64M | 94.32M | 95.62M | 96.67M | 100.82M | 105.88M | 107.26M | 109.65M | 111.71M | 111.17M | 111.46M | 114.41M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
International Flavors (IFF) Up 2% Since Last Earnings Report: Can It Continue?
International Flavors (IFF) reported earnings 30 days ago. What's next for the stock?
Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions
Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions
Morgan Stanley upgrades IFF to Overweight after stock pullback
Morgan Stanley analyst Lisa De Neve upgraded IFF to Overweight from Equal Weight with a price target of $110, down from $111. The firm said it sees an opportunity to buy the shares after a 12% share price pullback following...
IFF upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Lisa De Neve upgraded IFF to Overweight from Equal Weight with a price target of $110, down from $111, citing the recent share-price pullback.
International Flavors (IFF) International Revenue Performance Explored
Evaluate International Flavors' (IFF) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst
BofA Securities analyst Salvator Tiano upgraded International Flavors & Fragrances, Inc. IFF to Buy from Neutral, lowering the price forecast to $107 from $109.
Down -14.15% in 4 Weeks, Here's Why International Flavors (IFF) Looks Ripe for a Turnaround
International Flavors (IFF) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
International Flavors & Fragrances Inc. (IFF) Q3 2024 Earnings Call Transcript
International Flavors & Fragrances Inc. (NYSE:IFF ) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Michael DeVeau - Senior Vice President, Corporate Finance and Investor Relations Erik Fyrwald - Chief Executive Officer Glenn Richter -...
International Flavors Q3 Earnings Miss Estimates, Sales Rise Y/Y
IFF expects 2024 sales in the range of $11.3-$11.4 billion compared with prior stated $11.1-$11.3 billion.
International Flavors (IFF) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for International Flavors (IFF) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago...
Source: https://incomestatements.info
Category: Stock Reports